학술논문

Eculizumab for paroxysmal nocturnal hemoglobinuria: Two cases of successful pregnancy outcomes.
Document Type
Case Study
Source
Clinical Case Reports. May2024, Vol. 12 Issue 5, p1-6. 6p.
Subject
*PREGNANCY outcomes
*PAROXYSMAL hemoglobinuria
*HIGH-risk pregnancy
*ECULIZUMAB
*DISEASE incidence
*RARE diseases
Language
ISSN
2050-0904
Abstract
Key Clinical Message: Paroxysmal nocturnal hemoglobinuria is a rare disease with the incidence ranging from 0.08 to 0.57 per 100,000 person‐years. Up to 25% of cases in women are detected during pregnancy. We report two cases of successful pregnancy outcomes in patients treated with eculizumab, pointing out the importance of interdisciplinary approach in these high‐risk pregnancies. [ABSTRACT FROM AUTHOR]